Objective:

To evaluate the impact of continuous glucose monitoring (CGM) on maternal and neonatal outcomes in patients with gestational diabetes.

Approach:

Key Findings:

• Neonatal hypoglycemia was numerically lower with CGM (46% vs 65%), but not statistically significant.

Interpretation:

While CGM did not improve time in range, it was associated with significantly better maternal and neonatal outcomes, highlighting its potential benefits in managing gestational diabetes.

Limitations:

• Control group also underwent blinded CGM, which may not provide a true standard-of-care comparison.

Conclusion:

CGM improved maternal and neonatal outcomes in gestational diabetes patients, despite no significant difference in time in range.

Sources:

• Diabetes, Obesity and Metabolism
Source

Based on findings from:

CGM in Early Gestational Diabetes Improved Outcomes

Kathryn Wighton. MDSpire News, 2026.

https://news.mdspire.com/obgyn/articles/cgm-in-early-gestational-diabetes-improved-outcomes/

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.